{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:23:34Z","timestamp":1794349414056,"version":"4.9.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402290"],"award-info":[{"award-number":["82402290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7244525"],"award-info":[{"award-number":["7244525"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.117570","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:51:33Z","timestamp":1790185893000},"page":"117570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sonocavitation therapy for pancreatic cancer: Research progress, clinical application and future perspectives"],"prefix":"10.1016","volume":"29","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiti","family":"Shama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117570_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.117570_bib2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","article-title":"Overview and countermeasures of cancer burden in China","volume":"66","author":"Wang","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.isci.2026.117570_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11427-022-2218-x","article-title":"Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea","volume":"66","author":"Ju","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.isci.2026.117570_bib4","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117570_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/SLA.0000000000005628","article-title":"Outcome of Pancreatic Surgery During the First 6 Years of a Mandatory Audit Within the Dutch Pancreatic Cancer Group","volume":"278","author":"Suurmeijer","year":"2023","journal-title":"Ann. Surg."},{"key":"10.1016\/j.isci.2026.117570_bib6","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8182","article-title":"Metastatic pancreatic cancer: Mechanisms and detection","volume":"46","author":"Chen","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2026.117570_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.gastro.2017.11.280","article-title":"Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer","volume":"154","author":"Vennin","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.117570_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbcan.2019.01.007","article-title":"Reflections on depletion of tumor stroma in pancreatic cancer","volume":"1871","author":"Wang","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib9","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1158\/1078-0432.CCR-15-2010","article-title":"Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer","volume":"22","author":"Hingorani","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117570_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-020-01167-9","article-title":"PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102309","article-title":"KRAS Inhibitors- yes but what next? Direct targeting of KRAS- vaccines, adoptive T cell therapy and beyond","volume":"101","author":"Nagasaka","year":"2021","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.isci.2026.117570_bib13","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1200\/JCO.22.02630","article-title":"Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer","volume":"41","author":"Qin","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S2468-1253(23)00207-8","article-title":"The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy","volume":"8","author":"Hilmi","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.117570_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2022.11.035","article-title":"Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)","volume":"180","author":"Chen","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib16","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","article-title":"First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors","volume":"72","author":"Bendell","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.117570_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006136","article-title":"Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors","volume":"11","author":"Lemech","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152411","article-title":"Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer","volume":"52","author":"Guirguis","year":"2025","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152399","article-title":"Application prospects of tumor vaccines for pancreatic cancer: From TAAs to TSAs and combination strategies","volume":"52","author":"Lu","year":"2025","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117570_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103897","article-title":"Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer","volume":"77","author":"Zhang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.117570_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrd1417","article-title":"Microbubbles in medical imaging: current applications and future directions","volume":"3","author":"Lindner","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.117570_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.bioeng.6.040803.140126","article-title":"Mechanical bioeffects of ultrasound","volume":"6","author":"Dalecki","year":"2004","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.isci.2026.117570_bib24","doi-asserted-by":"crossref","DOI":"10.34133\/2022\/9807347","article-title":"Ultrasound-Mediated Drug Delivery: Sonoporation Mechanisms, Biophysics, and Critical Factors","volume":"2022","author":"Tu","year":"2022","journal-title":"BME Front."},{"key":"10.1016\/j.isci.2026.117570_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.colsurfb.2014.07.051","article-title":"Ultrasonically triggered drug delivery: breaking the barrier","volume":"123","author":"Husseini","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.isci.2026.117570_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202100885","article-title":"Sonoporation: Past, Present, and Future","volume":"7","author":"Rich","year":"2022","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.isci.2026.117570_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15212\/bioi-2020-0028","article-title":"Sonoporation: Underlying Mechanisms and Applications in Cellular Regulation","volume":"2","author":"Li","year":"2021","journal-title":"BIO Integration"},{"key":"10.1016\/j.isci.2026.117570_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121412","article-title":"Highlights in ultrasound-targeted microbubble destruction-mediated gene\/drug delivery strategy for treatment of malignancies","volume":"613","author":"Li","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.117570_bib29","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1038\/s41598-020-63653-w","article-title":"UTMD inhibit EMT of breast cancer through the ROS\/miR-200c\/ZEB1 axis","volume":"10","author":"Shi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117570_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12951-024-02453-0","article-title":"Hydralazine loaded nanodroplets combined with ultrasound-targeted microbubble destruction to induce pyroptosis for tumor treatment","volume":"22","author":"Huang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.isci.2026.117570_bib31","article-title":"Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy","volume":"13","author":"Han","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117570_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41416-022-02076-y","article-title":"Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect","volume":"128","author":"Liu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.irbm.2018.11.005","article-title":"Ultrasound-Targeted Microbubble Destruction (UTMD) for Localized Drug Delivery into Tumor Tissue","volume":"40","author":"Wischhusen","year":"2019","journal-title":"IRBM"},{"key":"10.1016\/j.isci.2026.117570_bib34","doi-asserted-by":"crossref","first-page":"27013","DOI":"10.1021\/acsami.2c02490","article-title":"In Situ Micro\u2013Nano Conversion Augmented Tumor-Localized Immunochemotherapy","volume":"14","author":"Sun","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.isci.2026.117570_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/mp4005244","article-title":"Ultrasound-Mediated Destruction of LHRHa-Targeted and Paclitaxel-Loaded Lipid Microbubbles Induces Proliferation Inhibition and Apoptosis in Ovarian Cancer Cells","volume":"11","author":"Liu","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2026.117570_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13534-017-0016-5","article-title":"Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications","volume":"7","author":"Lee","year":"2017","journal-title":"Biomed. Eng. Lett."},{"key":"10.1016\/j.isci.2026.117570_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100949","article-title":"Ultrasound mediated therapy: Recent progress and challenges in nanoscience","volume":"35","author":"Ouyang","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.isci.2026.117570_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2016.09.026","article-title":"Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications","volume":"241","author":"Boissenot","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11307-013-0672-5","article-title":"Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft","volume":"16","author":"Kotopoulis","year":"2014","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.isci.2026.117570_bib40","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.molpharmaceut.9b00416","article-title":"Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model","volume":"16","author":"Bressand","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2026.117570_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hbpd.2020.03.004","article-title":"Antitumor effect of VEGFR2-targeted microbubble destruction with gemcitabine using an endoscopic ultrasound probe: In vivo mouse pancreatic ductal adenocarcinoma model","volume":"19","author":"Shimamoto","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.isci.2026.117570_bib42","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ultrasmedbio.2023.01.014","article-title":"Ultrasound and Microbubbles Increase the Uptake of Platinum in Murine Orthotopic Pancreatic Tumors","volume":"49","author":"Haram","year":"2023","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.isci.2026.117570_bib43","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.7150\/jca.93802","article-title":"Ultrasound-targeted microbubble destruction improves the suppression and magnetic resonance imaging of pancreatic cancer with polyethyleneimine nanogels","volume":"15","author":"Liu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.02.021","article-title":"Sonoporation enhances liposome accumulation and penetration in tumors with low EPR","volume":"231","author":"Theek","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib50","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.7150\/thno.15164","article-title":"Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer","volume":"6","author":"Xing","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117570_bib59","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ultrasmedbio.2022.06.017","article-title":"Low-Intensity Focused Ultrasound Produces Immune Response in Pancreatic Cancer","volume":"48","author":"Joiner","year":"2022","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.isci.2026.117570_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114322","article-title":"UTMD inhibits pancreatic cancer growth and metastasis by inducing macrophage polarization and vessel normalization","volume":"160","author":"Lin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.117570_bib61","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1038\/s41598-024-54432-y","article-title":"Power-Doppler-based NH002 microbubble sonoporation with chemotherapy relieves hypoxia and enhances the efficacy of chemotherapy and immunotherapy for pancreatic tumors","volume":"14","author":"Wu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117570_bib67","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.22834","article-title":"UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy","volume":"8","author":"Lin","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117570_bib84","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jconrel.2022.11.016","article-title":"Effect of acoustic cluster therapy (ACT\u00ae) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancer","volume":"352","author":"Ng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib77","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/jmp.jmp_30_24","article-title":"Ultrasound-stimulated Microbubbles for Treatment of Pancreatic Cancer Cells with Radiation and Nanoparticles: In vitro Study","volume":"49","author":"Nakayama","year":"2024","journal-title":"J. Med. Phys."},{"key":"10.1016\/j.isci.2026.117570_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2018.04.018","article-title":"Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer","volume":"279","author":"Nesbitt","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejpb.2020.10.012","article-title":"An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer","volume":"157","author":"Gao","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.isci.2026.117570_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.actbio.2021.05.046","article-title":"Gemcitabine-loaded microbubble system for ultrasound imaging and therapy","volume":"130","author":"Delaney","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2026.117570_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejpb.2021.05.018","article-title":"Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction","volume":"165","author":"Logan","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.isci.2026.117570_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.151775","article-title":"Spatial-temporal-controlled NO gas and PARP1 siRNA delivery for alleviating the dilemma of deeper sonodynamic therapy in pancreatic cancer","volume":"490","author":"Tang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.isci.2026.117570_bib58","article-title":"Ultrasound-Responsive Microfluidic Microbubbles for Combination Tumor Treatment","volume":"4","author":"Huang","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.isci.2026.117570_bib51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2017.07.040","article-title":"Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer","volume":"262","author":"Sheng","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib57","doi-asserted-by":"crossref","first-page":"23737","DOI":"10.1021\/acsami.0c05308","article-title":"Magnetic Targeting and Ultrasound Activation of Liposome\u2013Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies","volume":"12","author":"Dwivedi","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.isci.2026.117570_bib52","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/acsbiomaterials.2c00069","article-title":"Cascade Drug Delivery through Tumor Barriers of Pancreatic Cancer via Ultrasound in Combination with Functional Microbubbles","volume":"8","author":"Zhang","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.isci.2026.117570_bib53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1148\/radiol.14140568","article-title":"Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection","volume":"274","author":"Pysz","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.isci.2026.117570_bib54","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/1078-0432.CCR-17-2057","article-title":"Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma","volume":"24","author":"Abou-Elkacem","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117570_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202500077","article-title":"Cascade Ultrasonic Cavitation Enables Microbubble\u2013Nanoparticle Hybrid to Broadly Accumulate and Penetrate into Pancreatic Ductal Adenocarcinoma","volume":"6","author":"Ye","year":"2025","journal-title":"Small Struct."},{"key":"10.1016\/j.isci.2026.117570_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s44341-025-00017-3","article-title":"The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness","volume":"2","author":"Neophytou","year":"2025","journal-title":"NPJ Biol. Phys. Mech."},{"key":"10.1016\/j.isci.2026.117570_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy","volume":"8","author":"Ju","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1582305","article-title":"Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets","volume":"16","author":"Pan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117570_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.fmre.2024.10.017","article-title":"Recent advances in ultrasound-targeted nanobubbles combined with cancer immunotherapy: Mechanisms, applications, and challenges","volume":"6","author":"Chen","year":"2026","journal-title":"Fundam. Res."},{"key":"10.1016\/j.isci.2026.117570_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2020.04.023","article-title":"Ultrasound in tumor immunotherapy: Current status and future developments","volume":"323","author":"Ho","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib66","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12325-008-0051-9","article-title":"Ultrasound-mediated microbubble destruction enhances gene transfection in pancreatic cancer cells","volume":"25","author":"Wang","year":"2008","journal-title":"Adv. Ther."},{"key":"10.1016\/j.isci.2026.117570_bib68","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s12672-025-03383-5","article-title":"CRISPR\/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook","volume":"16","author":"Noormohamadi","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib69","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41417-025-00959-9","article-title":"Gene editing in cancer therapy: overcoming drug resistance and enhancing precision medicine","volume":"32","author":"Park","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.isci.2026.117570_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-026-00627-z","article-title":"Applications of genome editing technologies in the treatment of human diseases","author":"Alshorman","year":"2026","journal-title":"Gene Ther."},{"key":"10.1016\/j.isci.2026.117570_bib71","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/pharmaceutics17081053","article-title":"Therapeutic pCRISPRi Delivery to Lung Squamous Cell Carcinoma by Combining Nanobubbles and Ultrasound","volume":"17","author":"Yamaguchi","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.117570_bib72","article-title":"High-Performance Delivery of a CRISPR Interference System via Lipid-Polymer Hybrid Nanoparticles Combined with Ultrasound-Mediated Microbubble Destruction for Tumor-Specific Gene Repression","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.isci.2026.117570_bib73","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/cancers15133382","article-title":"Radiotherapy in Pancreatic Cancer: To Whom, When, and How?","volume":"15","author":"Falco","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117570_bib74","first-page":"12","article-title":"The Current Role of Radiation in Pancreatic Cancer and Future Directions","volume":"22","author":"Hill","year":"2023","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.isci.2026.117570_bib75","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.zemedi.2023.04.007","article-title":"Radiation combined with ultrasound and microbubbles: A potential novel strategy for cancer treatment","volume":"33","author":"Sharma","year":"2023","journal-title":"Z. Med. Phys."},{"key":"10.1016\/j.isci.2026.117570_bib76","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231176376","article-title":"Focused Ultrasound and Ultrasound Stimulated Microbubbles in Radiotherapy Enhancement for Cancer Treatment","volume":"22","author":"Leong","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.isci.2026.117570_bib78","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijpharm.2015.09.047","article-title":"Acoustic Cluster Therapy (ACT) \u2013 A novel concept for ultrasound mediated, targeted drug delivery","volume":"495","author":"Sontum","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.117570_bib79","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1158\/1538-7445.AM2024-6221","article-title":"Abstract 6221: First-in-human study of acoustic cluster therapy consisting of PS101 combined with chemotherapy and insonation in patients with liver metastases of colorectal cancer origin","volume":"84","author":"Banerji","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117570_bib80","doi-asserted-by":"crossref","DOI":"10.1121\/10.0027527","article-title":"Acoustic cluster therapy: An overview of research in cancer treatment","volume":"155","author":"Bamber","year":"2024","journal-title":"J. Acoust. Soc. Am."},{"key":"10.1016\/j.isci.2026.117570_bib81","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS3145","article-title":"Phase I trial of acoustic cluster therapy (ACT) with chemotherapy in patients with liver metastases of gastrointestinal origin (ACTIVATE study)","volume":"39","author":"Banerji","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117570_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2016.06.018","article-title":"Acoustic Cluster Therapy (ACT) enhances the therapeutic efficacy of paclitaxel and Abraxane\u00ae for treatment of human prostate adenocarcinoma in mice","volume":"236","author":"van Wamel","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib83","series-title":"2019 IEEE International Ultrasonics Symposium (IUS)","first-page":"224","article-title":"Acoustic Cluster Therapy displays theranostic capability in enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice","author":"Bush","year":"2019"},{"key":"10.1016\/j.isci.2026.117570_bib85","doi-asserted-by":"crossref","DOI":"10.1118\/1.4808149","article-title":"Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study","volume":"40","author":"Kotopoulis","year":"2013","journal-title":"Med. Phys."},{"key":"10.1016\/j.isci.2026.117570_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.117570_bib87","doi-asserted-by":"crossref","first-page":"553","DOI":"10.21147\/j.issn.1000-9604.2018.05.09","article-title":"Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system","volume":"30","author":"Wang","year":"2018","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.isci.2026.117570_bib89","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00330-023-10210-4","article-title":"Clinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, open-label, randomised, controlled trial","volume":"34","author":"Han","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.isci.2026.117570_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.wfumbo.2025.100080","article-title":"Treatment of inoperable pancreatic adenocarcinoma with focused ultrasound and microbubbles in patients receiving chemotherapy","volume":"3","author":"Haram","year":"2025","journal-title":"WFUMB Ultrasound Open"},{"key":"10.1016\/j.isci.2026.117570_bib88","series-title":"Clinical study of ultrasound microbubble cavitation to enhance blood perfusion in pancreatic cancer","author":"Deng","year":"2024"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:44:11Z","timestamp":1794347051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226029494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":90,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226029494"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117570","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sonocavitation therapy for pancreatic cancer: Research progress, clinical application and future perspectives","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117570"}}